Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
20.5M
-
Shares change
-
+381K
-
Total reported value, excl. options
-
$395M
-
Value change
-
+$7.44M
-
Number of buys
-
43
-
Number of sells
-
-46
-
Price
-
$19.24
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2017
110 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2017.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.5M shares
of 46.4M outstanding shares and own 44.22% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.51M shares), Vanguard Group Inc (2.29M shares), DIMENSIONAL FUND ADVISORS LP (1.63M shares), FEDERATED INVESTORS INC /PA/ (1.05M shares), Invesco Ltd. (1.01M shares), STATE STREET CORP (974K shares), TEACHERS ADVISORS, LLC (550K shares), NORTHERN TRUST CORP (469K shares), JPMORGAN CHASE & CO (447K shares), and Bank of New York Mellon Corp (405K shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.